Genetron (GTH) Short Interest Ratio & Short Volume → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free GTH Stock Alerts $4.03 +0.01 (+0.25%) (As of 03/28/2024) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Genetron Short Interest DataCurrent Short Volume20,800 sharesPrevious Short Volume10,600 sharesChange Vs. Previous Month+96.23%Dollar Volume Sold Short$81,120.00Short Interest Ratio / Days to Cover0.5Last Record DateMarch 15, 2024Outstanding Shares31,620,000 sharesFloat Size27,660,000 sharesShort Percent of Float0.08%Today's Trading Volume412,600 sharesAverage Trading Volume51,662 sharesToday's Volume Vs. Average799% Short Selling Genetron ? Sign up to receive the latest short interest report for Genetron and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGTH Short Interest Over TimeGTH Days to Cover Over TimeGTH Percentage of Float Shorted Over Time Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide Genetron Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202420,800 shares $81,120.00 +96.2%0.1%0.5 $3.90 2/29/202410,600 shares $41,552.00 -6.2%0.0%0.3 $3.92 2/15/202411,300 shares $42,940.00 +73.9%0.0%0.3 $3.80 1/31/20246,500 shares $24,570.00 +58.5%0.0%0.2 $3.78 1/15/20244,100 shares $15,170.00 -81.5%0.0%0.1 $3.70 12/31/202322,100 shares $81,328.00 +123.2%0.1%0.4 $3.68 Get the Latest News and Ratings for GTH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genetron and its competitors with MarketBeat's FREE daily newsletter. 12/15/20239,900 shares $36,531.00 -36.1%0.0%0.2 $3.69 11/30/202315,500 shares $56,885.00 +80.2%0.1%0.4 $3.67 11/15/20238,600 shares $31,734.00 -49.4%0.0%0.2 $3.69 10/31/202317,000 shares $58,820.00 -87.8%0.1%0.4 $3.46 10/15/2023139,600 shares $166,124.00 -19.8%0.5%1.3 $1.19 9/30/2023174,000 shares $141,305.40 +6.9%0.2%3.1 $0.81 9/15/2023162,800 shares $133,496.00 +13.0%0.2%2.8 $0.82 8/31/2023144,100 shares $137,298.48 +9.8%0.2%2.5 $0.95 8/15/2023131,300 shares $120,796.00 +41.6%0.2%2.3 $0.92 7/31/202392,700 shares $86,071.95 -17.5%0.1%1.8 $0.93 7/15/2023112,400 shares $100,036.00 +8.8%0.1%2.6 $0.89 6/30/2023103,300 shares $96,079.33 +9.3%0.1%3.1 $0.93 6/15/202394,500 shares $87,875.55 -19.9%0.1%3.2 $0.93 5/31/2023118,000 shares $106,200.00 -25.6%0.1%4.9 $0.90 5/15/2023158,600 shares $149,068.14 -8.3%0.2%5.6 $0.94 4/30/2023172,900 shares $164,272.29 -1.5%0.2%4.7 $0.95 4/15/2023175,600 shares $158,040.00 -8.8%0.2%3.2 $0.90 3/31/2023192,500 shares $202,125.00 +41.7%0.2%2.5 $1.05 3/15/2023135,900 shares $124,212.60 -30.8%0.2%1.4 $0.91 2/28/2023196,400 shares $196,400.00 -25.2%0.2%1.6 $1.00 2/15/2023262,500 shares $279,562.50 +56.6%0.3%2 $1.07 1/31/2023167,600 shares $196,092.00 -41.7%0.2%1.1 $1.17 1/15/2023287,700 shares $339,486.00 -24.5%0.4%1.8 $1.18 12/30/2022380,800 shares $426,496.00 -19.8%0.5%2.6 $1.12 12/15/2022474,700 shares $507,929.00 +2.2%0.6%3.1 $1.07 11/30/2022464,700 shares $473,994.00 -16.2%0.6%2.5 $1.02 11/15/2022554,400 shares $531,336.96 +50.9%0.7%2.7 $0.96 10/31/2022367,500 shares $299,512.50 -8.0%0.5%1.5 $0.82 10/15/2022399,600 shares $321,717.96 +25.3%0.5%1.6 $0.81 9/30/2022319,000 shares $249,394.20 -29.6%0.4%1 $0.78 9/15/2022453,100 shares $475,755.00 +19.3%0.6%1.5 $1.05 8/31/2022379,800 shares $440,568.00 +66.7%0.5%1.4 $1.16 8/15/2022227,900 shares $243,853.00 -77.4%0.3%0.9 $1.07 7/31/20221,010,000 shares $1.08 million -4.7%1.2%4.3 $1.07Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide GTH Short Interest - Frequently Asked Questions What is Genetron's current short interest? Short interest is the volume of Genetron shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 20,800 shares of GTH short. 0.08% of Genetron's shares are currently sold short. Learn More on Genetron's current short interest. What is a good short interest percentage for Genetron? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.08% of Genetron's floating shares are currently sold short. Is Genetron's short interest increasing or decreasing? Genetron saw a increase in short interest in March. As of March 15th, there was short interest totaling 20,800 shares, an increase of 96.2% from the previous total of 10,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Genetron's float size? Genetron currently has issued a total of 31,620,000 shares. Some of Genetron's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Genetron currently has a public float of 27,660,000 shares. How does Genetron's short interest compare to its competitors? 0.08% of Genetron's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Genetron: Outset Medical, Inc. (16.60%), NGM Biopharmaceuticals, Inc. (4.52%), FitLife Brands, Inc. (0.11%), Omega Therapeutics, Inc. (21.69%), Cardiol Therapeutics Inc. (0.42%), Karyopharm Therapeutics Inc. (20.23%), Kinnate Biopharma Inc. (2.01%), Inotiv, Inc. (5.09%), Bright Health Group, Inc. (1.31%), Vistagen Therapeutics, Inc. (5.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Genetron stock? Short selling GTH is an investing strategy that aims to generate trading profit from Genetron as its price is falling. GTH shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Genetron? A short squeeze for Genetron occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GTH, which in turn drives the price of the stock up even further. How often is Genetron's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GTH, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Outset Medical Short Interest NGM Biopharmaceuticals Short Interest FitLife Brands Short Interest Omega Therapeutics Short Interest Cardiol Therapeutics Short Interest Karyopharm Therapeutics Short Interest Kinnate Biopharma Short Interest Inotiv Short Interest Bright Health Group Short Interest Vistagen Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GTH) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupTrump is sounding the alarmPreserve Gold